Systemic Microvascular Function in Patients With Resistant Hypertension

Status Completed

Clinical Trial Summary

It has been proposed that the modulation of the activity of the sympathetic nervous system, through renal sympathetic denervation, besides reducing blood pressure, would promote an improvement in vascular reactivity and consequent improvement of macro and microcirculation.

The present study aimed to investigate the influence of the renal sympathetic denervation on the skin microvascular function of patients presenting with resistant arterial hypertension.

Clinical Trial Description

Arterial hypertension is still a serious public health problem with considerable social and economic impact. Arterial hypertension is the result from a complex interaction between environmental and genetic factors that initiate and perpetuate elevated blood pressure. Studies show that about 10% of patients undergoing treatment have resistant hypertension, defined as high blood pressure refractory to at least three antihypertensive drugs. It is known that the sympathetic nervous system plays a fundamental role in the pathophysiology of hypertension, contributing to metabolic and vascular changes. The sympathetic nervous system has also a major role in the pathophysiology of arterial hypertension. Arterial hypertension has also been associated with functional microcirculatory alterations as well as systemic microvascular endothelial dysfunction in hypertensive patients, confirmed by different microcirculatory flowmetry techniques. In this context, it has been proposed that the modulation of the sympathetic nervous system through renal sympathetic denervation, besides reducing blood pressure, would promote an improvement in vascular reactivity and consequent improvement of macro and microcirculation.

The present study aimed to investigate the influence of the renal sympathetic denervation on the skin microvascular function of patients with resistant hypertension. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03243045
Study type	Observational [Patient Registry]
Source	National Institute of Cardiology, Laranjeiras, Brazil
Contact
Status	Completed
Phase
Start date	March 1, 2017
Completion date	January 6, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05684055` - "Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)	N/A
Active, not recruiting	`NCT05436730` - "Escape" Phenomenon of the Antihypertensive Therapy Efficacy
Not yet recruiting	`NCT03294070` - Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With Hypertension	Phase 4
Recruiting	`NCT01959997` - Comparison of Redo PVI With vs. Without Renal Denervation for Recurrent AF After Initial PVI	Phase 2
Completed	`NCT00983632` - Selective Vagus Nerve Stimulation in Human	N/A
Recruiting	`NCT06098300` - Effects of Change in Blood Pressure on Retinal Capillary Rarefaction in Patients With Arterial Hypertension
Completed	`NCT04564118` - A Retrospective Analysis of the Adherence to Clinical Practice Guidelines Using the "MedicBK" Digital Platform in Patients With Hypertension and Atrial Fibrillation
Terminated	`NCT04677322` - TO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET IN PATIENTS WITH HTA
Completed	`NCT04278001` - Clinical Usefullness of the Cuffless SOMNOtouch NIBP Device for 24-hour Ambulatory Blood Pressure Measurement	N/A
Withdrawn	`NCT03047538` - Fixed Combination for Lipid and Blood Pressure Control	Phase 4
Completed	`NCT03046264` - Invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis	N/A
Completed	`NCT02620995` - Effects of Sildenafil on Penile Vascular Function in Hypertensive Men With Erectile Dysfunction	Phase 4
Completed	`NCT02041832` - Detection of Subclinical Atrial Fibrillation in High Risk Patients Using Implantable Loop Recorder	N/A
Completed	`NCT01459120` - Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho	N/A
Completed	`NCT01546181` - Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases
Recruiting	`NCT01132001` - Ambulatory Versus Home Blood Pressure Measurement	N/A
Completed	`NCT01454583` - Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany	N/A
Recruiting	`NCT03917758` - Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors	N/A
Completed	`NCT03722524` - The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension
Completed	`NCT03539627` - Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Systemic Microvascular Function in Patients With Resistant Hypertension After Renal Sympathetic Denervation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms